“University of Surrey researchers said the virus could “help revolutionise treatment” for the cancer and reduce the risk of it recurring.”

A recent study, carried out by the cancer immunotherapy research team at University of Surrey, involving 15 patients with bladder cancer were given the cancer-killing coxsackievirus (CVA21) through a catheter one week before surgery to remove their tumours.

Prof Hardev Pandha said, “The virus gets inside cancer cells and kills them by triggering an immune protein – and that leads to signalling of other immune cells to come and join the party,” he said.

To read more about this exciting study, click on a link below:

Shopping Cart
Scroll to Top
%d bloggers like this: